Xbrane Biopharma
A biotechnology company specializing in the development of biosimilars.
XBRANE | ST
Overview
Corporate Details
- ISIN(s):
- SE0007789409 (+1 more)
- LEI:
- 5493008DKD05APTKQO39
- Country:
- Sweden
- Address:
- RETZIUS VÄG, 8, 171 65 Solna
- Website:
- https://xbrane.com/en/
- Sector:
- Manufacturing
Description
Xbrane Biopharma is a biotechnology company that specializes in the development of biosimilars—follow-on versions of approved biological drugs. The company's mission is to enhance the accessibility of biological treatments for serious diseases by creating more affordable alternatives. Xbrane utilizes a patented platform technology and efficient manufacturing systems, employing both bacterial and mammalian cells, to achieve lower production costs. Its development pipeline includes several biosimilar candidates, with a key product being a ranibizumab biosimilar.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-07-10 14:00 |
Susanna Helgesen (CFO) leaves Xbrane
|
English | 66.4 KB | ||
| 2020-07-10 14:00 |
Susanna Helgesen (CFO) lämnar Xbrane
|
Swedish | 67.3 KB | ||
| 2020-06-30 08:00 |
Change of number of shares and votes in Xbrane
|
English | 62.9 KB | ||
| 2020-06-30 08:00 |
Förändrat antal aktier och röster i Xbrane
|
Swedish | 63.6 KB | ||
| 2020-06-04 15:56 | English | 34.8 KB | |||
| 2020-05-29 13:00 |
Change of number of shares and votes in Xbrane
|
English | 64.2 KB | ||
| 2020-05-29 13:00 |
Förändrat antal aktier och röster i Xbrane
|
Swedish | 65.5 KB | ||
| 2020-05-28 10:15 |
Xbrane publishes a prospectus for admission to trading of shares on Nasdaq Stoc…
|
English | 81.2 KB | ||
| 2020-05-28 10:15 |
Xbrane offentliggör prospekt för upptagande av aktier på Nasdaq Stockholm i sam…
|
Swedish | 82.6 KB | ||
| 2020-05-22 10:36 | English | 33.5 KB | |||
| 2020-05-20 15:46 | English | 33.9 KB | |||
| 2020-05-20 08:30 |
Xbrane har genomfört en riktad nyemission av aktier om cirka 146 MSEK
|
Swedish | 86.5 KB | ||
| 2020-05-19 17:31 |
Xbrane intends to carry out a directed share issue through an accelerated book …
|
English | 82.3 KB | ||
| 2020-05-19 17:31 |
Xbrane offentliggör avsikt att genomföra en riktad nyemission av aktier genom e…
|
Swedish | 84.0 KB | ||
| 2020-05-14 18:30 |
Announcement from Xbrane Biopharma's annual general meeting
|
English | 70.7 KB |
Automate Your Workflow. Get a real-time feed of all Xbrane Biopharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Xbrane Biopharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Xbrane Biopharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-17 | Karl Martin Erik Åmark | Other | Buy | 1,864,223 | 318,782.13 SEK |
| 2025-01-17 | Karl Martin Erik Åmark | Other | Sell | 1,864,223 | 315,053.69 SEK |
| 2025-01-16 | Siavash Bashiri | Other | Sell | 1,519,932 | 260,212.36 SEK |
| 2025-01-16 | Siavash Bashiri | Other | Buy | 1,500,000 | 256,500.00 SEK |
| 2023-09-12 | Karl Martin Erik Åmark | Other | Buy | 4,000 | 129,000.00 SEK |
| 2023-09-12 | Karl Martin Erik Åmark | Other | Sell | 4,000 | 128,200.00 SEK |
| 2023-09-11 | Karl Martin Erik Åmark | Other | Sell | 2,000 | 62,140.00 SEK |
| 2023-09-08 | Siavash Bashiri | Other | Sell | 5,890 | 194,959.00 SEK |
| 2023-09-08 | Karl Martin Erik Åmark | Other | Other | 4,320 | 968.54 SEK |
| 2023-09-08 | Karl Martin Erik Åmark | Other | Other | 4,320 | N/A |
Peer Companies
